Related Experiment Video

Updated: Jul 31, 2026

Anticancer Efficacy of Photodynamic Therapy with Lung Cancer-Targeted Nanoparticles
08:03

Anticancer Efficacy of Photodynamic Therapy with Lung Cancer-Targeted Nanoparticles

Published on: December 1, 2016

Camptothecins and lung cancer: improved delivery systems by aerosol

N V Koshkina1, J C Waldrep, V Knight

  • 1Department of Molecular Physiology and Biophysics, Baylor College of Medicine, Houston, TX, USA. nvkoshki@mdanderson.org

Current Cancer Drug Targets
|July 23, 2003
PubMed

Insights

Camptothecins show promise for treating lung cancer, a leading cause of cancer deaths. This review explores their effectiveness, new drug formulations, and aerosol delivery methods for pulmonary tumors.

Area of Science:

  • Oncology
  • Pharmacology
  • Biochemistry

Background:

  • Lung cancer is a leading cause of cancer mortality globally with low cure rates.
  • Effective treatments for primary and recurrent lung cancer are urgently needed.
  • Topoisomerase I inhibitors, like camptothecins, are crucial for DNA replication and cell proliferation.

Purpose of the Study:

  • To review the current status of camptothecin and its derivatives in treating pulmonary cancers.
  • To discuss novel formulations and aerosol drug delivery systems for lung cancer treatment.
  • To explore the application of camptothecins in combination therapies for lung cancer.

Main Methods:

  • Review of preclinical and clinical studies on camptothecins in lung cancer.
  • Analysis of novel drug formulations and aerosol administration routes.
  • Evaluation of combination therapy strategies involving camptothecins.

Main Results:

  • Camptothecins have demonstrated activity against lung cancer and other solid tumors.
  • Development of new formulations and aerosol delivery methods is advancing treatment options.
  • Combination therapies show potential for enhanced efficacy in pulmonary oncology.

Conclusions:

  • Camptothecins represent a significant therapeutic avenue for lung cancer.
  • Novel drug delivery systems, particularly aerosol routes, offer improved treatment strategies.
  • Further research into combination therapies is warranted to optimize lung cancer treatment outcomes.

More Related Videos

Dry Powder and Nebulized Aerosol Inhalation of Pharmaceuticals Delivered to Mice Using a Nose-only Exposure System07:28

Dry Powder and Nebulized Aerosol Inhalation of Pharmaceuticals Delivered to Mice Using a Nose-only Exposure System

Published on: April 6, 2017

Orthotopic Transplantation of Syngeneic Lung Adenocarcinoma Cells to Study PD-L1 Expression06:03

Orthotopic Transplantation of Syngeneic Lung Adenocarcinoma Cells to Study PD-L1 Expression

Published on: January 19, 2019

Related Concept Videos

Drugs that Stabilize Microtubules01:15

Drugs that Stabilize Microtubules

Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Inhaled Medications01:23

Inhaled Medications

Inhaled medications are crucial for managing chronic obstructive pulmonary disease (COPD) and asthma. They are essential for effective treatment and control, ensuring optimal respiratory health and well-being. Inhaled medication delivers drugs directly to the lungs, providing a rapid onset of action and reducing systemic side effects compared to oral or injectable medications. Three primary types of inhalation devices are used to administer these medications: nebulizers, metered-dose inhalers...
Modified-Release Drug Delivery Systems: Site-Targeted01:24

Modified-Release Drug Delivery Systems: Site-Targeted

Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
Site-Targeted Drug Delivery Systems: Polymeric Carriers01:24

Site-Targeted Drug Delivery Systems: Polymeric Carriers

Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...